Alzheimer’s disease begins decades before the onset of any symptoms, such as memory loss. Consequently, early diagnosis increases the chances of slowing the disease down…
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that older adults with greater severity of hearing loss…
Researchers have used fruit flies to decipher an unexplained connection between Alzheimer’s disease and a genetic variation, revealing that it causes neurons to die.
The Food and Drug Administration (FDA) granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer’s disease something they haven’t…
Caregivers of people living with dementia are treated negatively by others and face discrimination, finds a new study led by UCL researchers.
A new Alzheimer’s drug is hitting the market—the first with clear-cut evidence that it can slow, by several months, the mind-robbing disease.
The human brain holds many clues about a person’s long-term health—in fact, research shows that a person’s brain age is a more useful and accurate…
Neurodegenerative diseases affect millions of people worldwide and as our life expectancy increases, more individuals are expected to be affected in the coming decades. Tauopathies…
The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in the early stages…
Scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today reported that an inflammatory trigger like one present…